Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations

No abstract is available for this paper.

• Publication year

  2018

• Venue

  American Journal of Cardiovascular Drugs

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40256-017-0251-2PMID 29027135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Randomized Trial on Statin Myopathy.

  2017cited by this paper
• Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.

  2017cited by this paper
• Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes

  2017cited by this paper
• Faculty Opinions recommendation of Continued statin prescriptions after adverse reactions and patient outcomes: A cohort study.

  2017cited by this paper
• Clinical and economic consequences of statin intolerance in the United States: Results from an integrated health system.

  2017cited by this paper
• Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia

  2017cited by this paper
• The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability

  2017cited by this paper
• Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.

  2017cited by this paper
• The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study

  2017cited by this paper
• Effects of Coenzyme Q10 on Skeletal Muscle Oxidative Metabolism in Statin Users Assessed Using 31P Magnetic Resonance Spectroscopy: a Randomized Controlled Study.

  2016cited by this paper
• Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.

  2016cited by this paper
• Statins Trigger Mitochondrial Reactive Oxygen Species-Induced Apoptosis in Glycolytic Skeletal Muscle

  2016cited by this paper
• The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy

  2016cited by this paper
• Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).

  2016cited by this paper
• A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles

  2016cited by this paper
• The nocebo effect in the context of statin intolerance.

  2016cited by this paper
• LBOS 01-04 THE TRUE INCIDENCE OF STATIN -RELATED ADVERSE EVENTS IN HYPERTENSIVE PATIENTS REVEALED BY COMPARISON OF BLINDED AND UN-BLINDED USE OF STATIN IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT).

  2016cited by this paper
• Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model.

  2016cited by this paper
• Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials.

  2015cited by this paper
• Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression

  2015cited by this paper
• The Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination Therapy.

  2015cited by this paper
• Muscle-related side-effects of statins: from mechanisms to evidence-based solutions

  2015cited by this paper
• Trends in the use of complementary health approaches among adults: United States, 2002-2012.

  2015cited by this paper
• A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.

  2015influential reference
• Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study.

  2015cited by this paper
• Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition.

  2015cited by this paper
• Association between trajectories of statin adherence and subsequent cardiovascular events

  2015cited by this paper
• Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.

  2015cited by this paper
• Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.

  2015cited by this paper
• Coenzyme Q10 Supplementation Decreases Statin-Related Mild-to-Moderate Muscle Symptoms: A Randomized Clinical Study

  2014cited by this paper
• An assessment by the Statin Muscle Safety Task Force: 2014 update.

  2014cited by this paper
• Application of new cholesterol guidelines to a population-based sample.

  2014cited by this paper
• A systematic review of statin-induced muscle problems in clinical trials.

  2014cited by this paper
• Simvastatin impairs exercise training adaptations.

  2013cited by this paper
• Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.

  2013cited by this paper
• Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.

  2013cited by this paper
• Coenzyme Q(10) and selenium in statin-associated myopathy treatment.

  2013cited by this paper
• No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy

  2013cited by this paper
• Effect of coenzyme Q10 supplementation on statin-induced myalgias.

  2012cited by this paper
• Impact of Coenzyme Q-10 on Parameters of Cardiorespiratory Fitness and Muscle Performance in Older Athletes Taking Statins

  2012cited by this paper
• Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.

  2012cited by this paper
• Effect of statins on creatine kinase levels before and after a marathon run.

  2012cited by this paper
• Effect of Statins on Skeletal Muscle Function

  2012cited by this paper
• Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.

  2011cited by this paper
• Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats.

  2011cited by this paper
• Coenzyme Q10: The essential nutrient

  2011cited by this paper
• Atorvastatin treatment reduces exercise capacities in rats: involvement of mitochondrial impairments and oxidative stress.

  2011cited by this paper
• Transcriptional deficits in oxidative phosphorylation with statin myopathy

  2011cited by this paper
• Statin‐Associated Muscle‐Related Adverse Effects: A Case Series of 354 Patients

  2010cited by this paper
• Coenzyme Q10: is there a clinical role and a case for measurement?

  2008cited by this paper
• Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals

  2008cited by this paper
• Statin myopathy: Incidence, risk factors, and pathophysiology

  2007cited by this paper
• Effect of Coenzyme Q10 supplementation on exercise-induced muscular injury of rats.

  2007cited by this paper
• The role of coenzyme Q10 in statin-associated myopathy: a systematic review.

  2007cited by this paper
• Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.

  2007cited by this paper
• Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.

  2007influential reference
• Safety assessment of PureSorb-Q40 in healthy subjects and serum coenzyme Q10 level in excessive dosing.

  2007cited by this paper
• Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.

  2007cited by this paper
• Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study

  2005cited by this paper
• Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity

  2005cited by this paper
• High‐dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial

  2005cited by this paper
• Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity.

  2005cited by this paper
• Muscle and plasma coenzyme Q10 concentration, aerobic power and exercise economy of healthy men in response to four weeks of supplementation.

  2005cited by this paper
• Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.

  2004cited by this paper
• Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems.

  2004cited by this paper
• Coenzyme Q intake elevates the mitochondrial and tissue levels of Coenzyme Q and alpha-tocopherol in young mice.

  2003cited by this paper
• Safety considerations for statins

  2002cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Lovastatin increases exercise-induced skeletal muscle injury.

  1997cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Inhalation of levomepromazine in severe acute asthma.

  1994cited by this paper

• Network Pharmacology Insights Into Statin-Induced Coenzyme Q10 Deficiency: Lipid Metabolic Crosstalk, TNF-MAPK Signaling, and Muscle Toxicity.

  2025cites this paper
• Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods

  2023cites this paper
• TPGS and Doca Dual-Modified Mesoporous Silica Nanoparticle-Supported Lipid Bilayers Enhance the Efficient Delivery and in Vivo Absorption of Coenzyme Q10

  2023cites this paper
• Statins Neuromuscular Adverse Effects

  2022cites this paper
• Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.

  2022cites this paper
• Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels

  2022cites this paper
• Coenzyme Q10 for Patients With Cardiovascular Disease: JACC Focus Seminar.

  2021cites this paper
• Stability of Reduced and Oxidized Coenzyme Q10 in Finished Products

  2021cites this paper
• Evidencia del manejo de miopatías asociadas a estatina con coenzima Q10

  2021influential citation
• Assembly and Characterization of Biocompatible Coenzyme Q10 -Enriched Lipid Nanoparticles.

  2020cites this paper
• Coenzyme Q10 and SAMS

  2020cites this paper
• Introduction

  2020cites this paper
• Coenzyme Q10.

  2019cites this paper
• Research Roundup

  2018cites this paper
• Creatine supplementation does not alter the creatine kinase response to eccentric exercise in healthy adults on atorvastatin.

  2018cites this paper
• Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms-A Good Idea, but….

  2018cites this paper
• Important drug-micronutrient interactions: A selection for clinical practice

  2018cites this paper
• Coenzyme Q10 or Creatine Counteract Pravastatin-Induced Liver Redox Changes in Hypercholesterolemic Mice

  2018cites this paper
• A dvances in the Study of Statin-associated Muscle Symptoms

  year unknowncites this paper